Study to Monitor the Occurrence of Viral Variants in Patients With Compromised Immune Systems Being Treated for COVID-19
NCT05305651
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
217
Enrollment
INDUSTRY
Sponsor class
Conditions
COVID-19
Interventions
DRUG:
Sotrovimab
Sponsor
GlaxoSmithKline